References
- 1. Blount BW, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Acad Fam Phys 2002;66:435-40.
- 2. Kyriakis KP, Palamaras I, Terzoudi S, Emmanuelides S, Michailides C, Pagana G. Epidemiologic aspects of rosacea. J Am Acad Dermatol 2005;53:918-9.
- 3. Berth-Jones J. Rosacea, perioral dermatitis and similar dermatoses, flushing and flushing syndromes. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. 8th ed. Oxford: Wiley-Blackwell; 2010. p. 43.1-20.
- 4. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2002;46:584-7.
- 5. Pelle MT. Rosacea. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick‘s dermatology in general medicine.7th ed. New York: McGraw-Hill; 2008. p. 703-10.
- 6. Gupta AK, Gover MD. Azelaic acid (15% gel) in the treatment of acne rosacea. Int J Dermatol 2007;46:533-8.
- 7. Jappe U, Schafer T, Schnuch A, Uter W. Contact allergy in patients with rosacea: a clinical-based prospective epidemiological study. J Eur Acad Dermatol Venereol 2008;22:1208-14.
- 8. Van de Scheur MR, Van der Waal RI, Starink TM. Lupus miliaris disseminatus faciei: a distinctive rosacea-like syndrome and not a granulomatous form of rosacea. Dermatology 2003;206:120-3.
- 9. Ioffreda MD. Inflammatory disorders of hair follicles, sweat glands, and cartilage. In: Elder DE, editor. Lever‘s histopathology of the skin. 9th ed. Philadelphia: Lippincott Williams & Wilkins. 2005. p. 469-512.
- 10. Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol 2010;24:565-71.
- 11. Yuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S. Systematic review of rosacea treatments. J Am Acad Dermatol Venereol 2007;56:107-15.
- 12. Karabulut AA, Izol Setrel B, Eksioglu HM. A randomized, single-blind, placebo controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea. J Eur Acad Dermatol Venereol 2008;2002:729-34.
- 13. Mostafa FF, El Harras MA, Gooma SM, Al Mokadem S, Nassar AA, Abdel Gawad EH. Comparative study of some treatment modalities of rosacea. J Eur Acad Dermatol Venereol 2009;23:22-8.
- 14. Sehgal VN, Sharma S, Sardana K. Rosacea-acne rosacea: efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointment. J Eur Acad Dermatol Venereol 2008;22:1366-8.